Skip to content
left end
left end
right end

Dr Michelle Cummins



Dr Michelle Cummins

Current Post:


Consultant Paediatric Haematologist

Contact Details:


T: 0117 342 8752 (secretary)

E: Michelle.Cummins@uhbristol.nhs,uk

Special Clinical Interests:



Philadelphia Positive Acute Lymphoblastic Leukaemia

Membership of professional bodies:


Member of Royal College of Pathologists and British Society of Haematology


Professional profile/background:


I qualified from Charing Cross & Westminster Medical School in 1992 and trained in Haematology in London and Bristol. In 2005, I was appointed as Consultant Paediatric Haematologist at Bristol Royal Hospital for Children. With colleagues,  I am responsible for providing and developing the paediatric tertiary malignant haematology service for Bristol and the South West, and a Supra-regional Stem Cell Transplantation service,  offering autologous, allogeneic and cord blood for children with malignant and non-malignant disorders.   I am the Lead for paediatric Haemoglobinopathy and Red cell disorders for Bristol and South West and aim to bid to be the Haemoglobinopathy Coordinating Centre for the region in the new proposed Haemoglobinopathy Service Commissioning Model. I am Paediatric Lead for Intrathecal chemotherapy and Transfusion. 

Nationally I am the Lead for Paediatric Philadelphia Positive Acute Lymphoblastic Leukaemia (Ph+ ALL), and UK Chief Investigator on the current International Ph + ALL study, EsPhALL 2017. I am a local Principal Investigator in multiple clinical trials and am a member of the NCRI Childhood Leukaemia Sub-Group.  In June 2014 I was appointed as Chair of UK Childhood Leukaemia Clinicians Network, the key organisation representing all paediatric leukaemia principal treatment centres in the UK.  As part of this role I have enabled the development of national guidelines and taken part in stakeholder consultations with the National Institute for Health and Care Excellence. I have recently been appointed as a clinical expert on the National CAR-T Clinical Panel (NCCP) for Acute Lymphoblastic Leukaemia.


Links to research publications: